Blaustein, Germany

Nadine Hagedorn



 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Blaustein, DE (2014 - 2018)
  • Frankfurt-am-Main, DE (2019 - 2023)

Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Nadine Hagedorn

Introduction

Nadine Hagedorn, an innovative inventor based in Blaustein, Germany, has made significant contributions to the field of biocompatible preparations for ophthalmology. With three patented inventions to her name, Hagedorn is a leading figure in enhancing medical practices related to eye surgeries.

Latest Patents

Nadine Hagedorn's latest patents focus on a groundbreaking dye solution. This invention pertains to a water-based, biocompatible, and non-cytotoxic preparation designed for the selective staining of internal limiting membranes (ILM) and/or epiretinal membranes (ERM) in both human and animal eyes. Additionally, the patent includes a kit that features this advanced water-based preparation, showcasing Hagedorn's commitment to improving surgical outcomes.

Career Highlights

Currently, Hagedorn is affiliated with Fluoron GmbH, a company that specializes in innovative medical solutions. Her work at Fluoron reflects her dedication to developing effective tools for eye care professionals, thus aiding in invaluable medical advancements. Throughout her career, she has established a reputation for her innovative approach and technical expertise.

Collaborations

In her professional journey, Nadine collaborates with skilled coworkers, including Christian Lingenfelder and Bastian Theisinger. Together, they contribute to the dynamic environment at Fluoron GmbH, promoting a culture of innovation and teamwork.

Conclusion

Nadine Hagedorn continues to be an inspiring figure in the field of ophthalmology through her innovative patents and collaborative spirit. Her contributions not only advance medical technology but also aim to enhance the quality of care for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…